Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

I am the Person at the End of Your Pipeline: A Patient Perspective on the Future of Radiopharma

By | 14 July 2026

My neuroendocrine cancer and theranostics journey: what early radioligand therapy has made possible
A passion for connecting with stakeholders – every job in theranostics contributes to the wellbeing of patients like me
Beyond access: helping patients understand, trust, and embrace radiopharmaceutical innovation